Back to Stock Analysis

Fever-Tree$FEVR

8 research articles

Research Articles

Fever-Tree: A Premium Business?

By TSOH Investment Research • 2023-09-18T10:30:15.289Z

Fever-Tree: A Premium Business?

By TSOH Investment Research • 2023-09-18T10:30:15.289Z

Fever-Tree: A Broader Opportunity

By TSOH Investment Research • 2024-04-01T10:30:59.209Z

Fever-Tree: "Spreading Our Wings"

By TSOH Investment Research • 2024-09-19T10:31:46.419Z

Fever-Tree: "A Great Blueprint"

By TSOH Investment Research • 2025-09-18T10:31:41.831Z

Fevertree - FEVR on LSE - Mcap £1.1bn @ 900p - Premium soft drinks - stock down 25% on revised EBITDA guidance today due to cost inflation (claimed transitory). EV / Sales c2.6x versus 7.5x for peers.

By Insider Ideas • 2022-07-15T13:12:47.242Z

Fevertree - all recent transactions in tabular format

By Insider Ideas • 2022-10-04T16:17:34.894Z

#FEVR Fever-Tree - is this a GLOBAL consumer blue-chip in the making?

By Insider Ideas • 2023-03-29T15:33:36.756Z